• English ENGLISH
  • Arabic ARABIC
  • French FRENCH
  • Spanish SPANISH
  • Portuguese PORTUGUESE
  • Romanian ROMANIAN
  • Greek GREEK
  • Russian RUSSIAN

Shareholder's Information

Investment Overview

Insights on growth, governance, and investors

  • Shareholders Information
  • Performance Highlights
  • Reports & Fillings
  • Corporate Governance
Stock Information

Track Our Stock Performance in Real Time

CURRENCY USD
MARKET BSE
ISIN CODE INE767A01016
IRN TICKER CODE 524348
INDUSTRY PHARMACEUTICALS
Contact Us

Investor Contact & Compliance Officers


Level 9, Paddington Central,
2 Kingdom Street,
London, England,
W2 6BD, Uk.

TEL: +44-7767285304
relations@vertexbiocenter.com


Determining Materiality

Dr. Brooks Jason Mark
Chairman & CEO

Christopher J Rhodes
Jt. Managing Director

Magnus Johansson
Chief Financial Officer & COO


Level 9, Paddington Central,
2 Kingdom Street,
London, England,
W2 6BD, Uk.

TEL: +44-7767285304
relations@vertexbiocenter.com
www.vertexbiocenter.com


Registrar & Share Transfer Agent

MUFG Intime UK Private Limited
(Formerly known as Link Intime UK Private Limited)

Unit: Vertex Bio Center Limited


Level 9, Paddington Central,
2 Kingdom Street,
London, England,
W2 6BD, Uk.

TEL: +44-7767285304
relations@vertexbiocenter.com


Shareholder Grievances &
Nodal Officer

Anna Sundgren
Director of Business Development &
Compliance Officer

Title Download
Notice of 40th Annual General Meeting
Annual Report 2024-25
Notice of 39th Annual General Meeting
Annual Report 2023-24
Notice of 38th Annual General Meeting
Annual Report 2022-23
Annual Report 2021-22
Annual Report 2020-21
Annual Report 2019-20
Annual Report 2018-19
Annual Report 2017-18
Annual Report 2016-17
Annual Report 2015-16
Annual Report 2014-15
Annual Report 2013-14
Annual Report 2012-13